Lataa...
PD-L1 and IDO1 are Expressed in Poorly-Differentiated Thyroid Carcinoma
BACKGROUND: Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of thyroid cancer that currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have shown to be an effective treatment for a variety of carcinomas. In this study, we explore whether immune...
Tallennettuna:
| Julkaisussa: | Endocr Pathol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6500591/ https://ncbi.nlm.nih.gov/pubmed/29372535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12022-018-9514-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|